Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The goal is to find the dose that provides effective appetite reduction and metabolic benefit with manageable or absent side effects
Efficacy comparison by clinical trial data The most relevant head-to-head data comes from the SURPASS-2 trial (tirzepatide vs semaglutide 1 mg for type 2 diabetes) and the SURMOUNT-5 trial (tirzepatide vs semaglutide 2.4 mg for obesity)
Weight-loss benefit builds as the dose climbs toward the 2.4 mg maintenance target
Ozempic and Adderall each have their own risks, including side effects and contraindications
We accept a variety of insurance plans, manage prior authorizations, and offer comprehensive care coordination
US$ 22.87
US$ 26.33
US$ 29.56
US$ 27.46
US$ 28.07
